Atty's Claims Back Up Penalties In Biotech Fraud, SEC Says
The U.S. Securities and Exchange Commission has renewed its demand for more than $1 million from a onetime biotech chief executive, telling a New Jersey federal court that his attorney confirmed...To view the full article, register now.
Already a subscriber? Click here to view full article